Valproic Acid
Valproic Acid is a pharmaceutical drug with 94 clinical trials. Currently 6 active trials ongoing. Historical success rate of 78.4%.
Success Metrics
Based on 58 completed trials
Phase Distribution
Phase Distribution
40
Early Stage
28
Mid Stage
14
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
75.3%
58 of 77 finished
24.7%
19 ended early
6
trials recruiting
94
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease
Valproic Acid/Simvastatin Plus Gemcitabine/Nab-paclitaxel Based Regimens in Untreated Metastatic Pancreatic Adenocarcinoma Patients
Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal Melanoma
A Study to Evaluate the Effects of Lithium, Valproic Acid, and Lamotrigine on the Pharmacokinetics of KarXT and Effects of KarXT on the Pharmacokinetics of Lithium, Valproic Acid, and Lamotrigine in Healthy Participants
Population Pharmacokinetics of Antiepileptic in Pediatrics
Clinical Trials (94)
Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease
Valproic Acid/Simvastatin Plus Gemcitabine/Nab-paclitaxel Based Regimens in Untreated Metastatic Pancreatic Adenocarcinoma Patients
Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal Melanoma
A Study to Evaluate the Effects of Lithium, Valproic Acid, and Lamotrigine on the Pharmacokinetics of KarXT and Effects of KarXT on the Pharmacokinetics of Lithium, Valproic Acid, and Lamotrigine in Healthy Participants
Population Pharmacokinetics of Antiepileptic in Pediatrics
Efficacy Comparison Between Levetiracetam and Valproic Acid in Pediatric Patients With Status Epilepticus
A Study to Investigate Treatment of HU and VPA, or 6-MP and VPA in Unfit AML/HR-MDS Patients
Avelumab With Valproic Acid in Virus-associated Cancer
Seizure Treatment in Glioma
SCN2A Polymorphisms Are Associated With Response to Valproic Acid in Paediatric Population(Pakistan)
Sorafenib, Valproic Acid, and Sildenafil in Treating Patients With Recurrent High-Grade Glioma
Valproate Versus Topiramate in Migraine
Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
Valproic Acid in Combination With Bevacizumab and Oxaliplatin/Fluoropyrimidine Regimens in Patients With Ras-mutated Metastatic Colorectal Cancer
Valproic Acid Plus Cisplatin and Cetuximab in Recurrent and/or Metastatic Squamous Cell Carcinoma of Head and Neck
Study of Safety and Dosing Effect on SMN Levels of Valproic Acid (VPA) in Patients With Spinal Muscular Atrophy
Preoperative Valproic Acid and Radiation Therapy for Rectal Cancer
Valproic Acid and Its Effects on HIV Latent Reservoirs
The Benefit and Safety of Older Generation Anti-Epileptic Drugs (AEDs) in Drug-Resistant Epilepsy Children
Valproic Acid (VPA) for Acute Kidney Injury (AKI) in Liver Transplant Patients
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 94